JOIN OUR LONG TERM VISION IN Infectious diseases
Evotec provides bespoke anti-infective research and development in three main therapeutic areas, Antimicrobial Resistance (AMR), Virology and Global Health, advancing projects from target ID to the Clinic. We have established a leading-edge platform enabling the discovery and development of new therapies and therapeutic approaches to treat and prevent serious and life-threatening infections. Integration, innovation and efficiency are the main elements characterising Evotec’s expertise. This also reaches beyond conventional antimicrobial agents into multiple alternative modalities such as targeting virulence attributes, specific pathogen antibodies, combination therapies, antimicrobial peptides (AMPs), and phage technologies
Our Anti-infective experts will be in a attendance at I4ID 2021 and would welcome the opportunity to discuss your projects
Please request a personal meeting below, alternatively email Nadir.Bessila@evotec.com
OUR ATTENDEES
Antoine Alam, VP Virology |
|
Hugh Watson, Principle Manager, Virology Clinical Development |
|
Francesca Berbardini, VP In Vitro Biology |
Sebastien Coyne Group Leader In Vitro Biology |
||
|
Kara Carter, Virology Entrepreneur in Residence |
Lilia Boucinha Team Leader, Global Bioinformatics |
Learn more